Related Experiment Videos
Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study
Sean J Pittock1, Robyn L McClelland, William T Mayr
1Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Annals of Neurology
|August 5, 2004
Summary
Patients with longer-lasting Multiple Sclerosis (MS) and lower disability are more likely to remain stable. Over 90% of those with benign MS (EDSS ≤ 2 for 10+ years) show no progression, aiding treatment decisions.
Area of Science:
- Neurology
- Clinical Epidemiology
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease.
- Understanding disease progression is crucial for patient management.
Purpose of the Study:
- To evaluate long-term stability in a Multiple Sclerosis (MS) cohort.
- To identify factors associated with disease stability in MS patients.
Main Methods:
- Follow-up study of the 1991 Olmsted County MS prevalence cohort in 2001.
- Analysis of disease duration and disability status (Expanded Disability Status Scale - EDSS).
Main Results:
- Longer MS duration and lower disability scores correlate with increased stability.
- Patients with benign MS (EDSS ≤ 2 for ≥ 10 years) have >90% chance of remaining stable.
- This stable subgroup represents 17% of the total MS prevalence cohort.
Conclusions:
- Disease duration and low disability are strong predictors of long-term stability in MS.
- Findings support informed therapeutic decision-making regarding immunomodulatory treatments for stable MS.
- Identifies a significant patient group with a high likelihood of remaining stable.